Your browser doesn't support javascript.
loading
The Burden of Neonatal Abstinence Syndrome, Opioids, and COVID-19 in Wisconsin.
Johnson, Peter; Cabacungan, Erwin; Yan, Ke; Dasgupta, Mahua; Broad, Jennifer; Kemp, Madeline; Ryan, Kelsey.
Afiliação
  • Johnson P; Medical College of Wisconsin, Milwaukee, Wisconsin, pjohnson@mcw.edu.
  • Cabacungan E; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Yan K; Quantititive Health Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Dasgupta M; Quantititive Health Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Broad J; Wisconsin Department of Health Services, Madison, Wisconsin.
  • Kemp M; Wisconsin Department of Health Services, Madison, Wisconsin.
  • Ryan K; Centers for Disease Control and Prevention/CSTE Applied Epidemiology Fellowship Program, Madison, Wisconsin.
WMJ ; 122(5): 456-463, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38180945
ABSTRACT

INTRODUCTION:

Wisconsin experienced overlapping and accelerating epidemics of opioid use and COVID-19 after March 2020. We hypothesized that Wisconsin neonatal abstinence syndrome rates increased after March 2020 alongside other markers of opioid burden.

METHODS:

Retrospective cohort analysis examined deidentified Wisconsin census, birth certificate, death certificate, hospital discharge, Prescription Drug Monitoring Program, emergency medical service run, and COVID-19 diagnosis records spanning January 1, 2019, through December 31, 2021. January 2019 through March 2020 was considered before the onset of COVID-19 (pre); April 2020 through December 2021 was considered post-onset of COVID-19 (post). Wisconsin Department of Health Services guidelines defined 5 Wisconsin regions. Rates pre- to post-onset were compared with P values < 0.05 considered statistically significant.

RESULTS:

Of 1362 patients, 83.3% completed a COVID-19 vaccination series. Younger patients had increased odds of not completing a COVID-19 vaccination series (mean [SD] 46.7 [14.7] vs 54.3 [15.8]; OR 1.03; 95% CI, 1.02-1.04; P < 0.001). Those who identified as non-White (1.88; 95% CI, 1.16-3.04; P = 0.010) or current smoker (1.85, 95% CI, 1.85-2.79; P = 0.004) had increased odds of not completing a COVID-19 vaccination series. Those who resided in rural ZIP codes (1.81; 95% CI, 1.35-2.43; P < 0.001), had not received a 2019-2020 influenza vaccine (5.13; 95% CI, 3.79-6.96; P < 0.001), or had lower comorbidity scores (2.95; 95% CI, 1.98-4.41; P < 0.001) had higher odds of not completing a COVID-19 vaccination series.

CONCLUSIONS:

Opioid-associated morbidity and mortality increased in Wisconsin during the study period, including among females age 15 to 44 years. Despite increased opioid burden, neonatal abstinence syndrome incidence decreased in the Southeastern Region. Ongoing neonatal abstinence syndrome and opioid analysis may benefit from region-based contextualization.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência Neonatal / COVID-19 Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Newborn País/Região como assunto: America do norte Idioma: En Revista: WMJ Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência Neonatal / COVID-19 Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Newborn País/Região como assunto: America do norte Idioma: En Revista: WMJ Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article